Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ELAB SOLUTIONS CORPORATION

NPI: 1275766370 · SANDY SPRINGS, GA 30342 · Clinical Medical Laboratory · NPI assigned 08/24/2009

$801K
Total Medicaid Paid
26,673
Total Claims
12,776
Beneficiaries
36
Codes Billed
2018-01
First Month
2018-04
Last Month

Provider Details

Authorized OfficialSMITH, MARTY (PRESIDENT/CEO)
NPI Enumeration Date08/24/2009

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 26,673 $801K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 6,450 2,595 $244K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 2,293 1,233 $244K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,641 2,913 $226K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 596 490 $46K
81025 1,431 494 $29K
80053 Comprehensive metabolic panel 157 116 $1K
86803 116 83 $1K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 150 113 $1K
86709 111 77 $1K
86705 109 76 $1K
86703 76 54 $742.69
80362 923 430 $741.76
80348 923 430 $662.68
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 86 31 $403.51
80355 821 390 $289.30
84311 856 378 $286.46
36415 Collection of venous blood by venipuncture 96 81 $276.81
80349 334 186 $250.52
80369 162 119 $159.48
80324 269 173 $146.52
80346 349 227 $139.52
80061 Lipid panel 27 24 $132.60
80361 151 120 $107.10
80356 147 117 $101.02
80373 825 399 $97.98
80365 151 119 $86.52
80354 130 102 $86.52
80358 153 119 $68.03
80353 145 112 $59.40
82570 880 393 $51.76
83986 874 389 $44.40
80367 57 47 $36.48
83992 78 64 $35.26
80359 17 16 $20.50
80336 47 35 $0.00
80321 42 31 $0.00